These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7737354

  • 21. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells.
    Davis MG, Huang ES.
    Biotechnol Appl Biochem; 1988 Feb; 10(1):6-12. PubMed ID: 2841949
    [Abstract] [Full Text] [Related]

  • 22. EIa-mediated transactivation of the adenovirus EIIa early promoter is restricted in undifferentiated F9 cells.
    Boeuf H, Jansen-Durr P, Kédinger C.
    Oncogene; 1990 May; 5(5):691-9. PubMed ID: 2161097
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The adenovirus-5 12S E1a protein, but not the 13S induces expression of the endoA differentiation marker in F9 cells.
    Velcich A, Ziff EB.
    Oncogene; 1989 Jun; 4(6):707-13. PubMed ID: 2543941
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic manipulation of mammalian dictyate oocytes: factors affecting transient expression of microinjected DNA templates.
    Bevilacqua A, Kinnunen LH, Mangia F.
    Mol Reprod Dev; 1992 Oct; 33(2):124-30. PubMed ID: 1329862
    [Abstract] [Full Text] [Related]

  • 28. Repressor-like factor that interacts with SV40 promoter/enhancer and expressed during differentiation of embryonal carcinoma F9 cells.
    Taniguchi Y, Kitagawa Y.
    Biosci Biotechnol Biochem; 1996 Apr; 60(4):721-3. PubMed ID: 8829548
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Optimization of the Tet-On system for inducible expression of RAGE.
    Shaikh S, Nicholson LF.
    J Biomol Tech; 2006 Sep; 17(4):283-92. PubMed ID: 17028168
    [Abstract] [Full Text] [Related]

  • 31. Expression of chimeric human transferrin genes in vitro.
    Fischbach K, Lu Y, Tiffany-Castiglioni E, Minter A, Bowman BH, Adrian GS.
    J Neurosci Res; 1990 Dec; 27(4):633-41. PubMed ID: 2079722
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Precise conditional immortalization of mouse cells using tetracycline-regulated SV40 large T-antigen.
    Anastassiadis K, Rostovskaya M, Lubitz S, Weidlich S, Stewart AF.
    Genesis; 2010 Apr; 48(4):220-32. PubMed ID: 20146354
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Highly inducible expression from vectors containing multiple GRE's in CHO cells overexpressing the glucocorticoid receptor.
    Israel DI, Kaufman RJ.
    Nucleic Acids Res; 1989 Jun 26; 17(12):4589-604. PubMed ID: 2546123
    [Abstract] [Full Text] [Related]

  • 38. The F9-EC cell line as a model for the analysis of differentiation.
    Alonso A, Breuer B, Steuer B, Fischer J.
    Int J Dev Biol; 1991 Dec 26; 35(4):389-97. PubMed ID: 1666294
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
    Vannice JL, Grove JR, Ringold GM.
    Mol Pharmacol; 1983 May 26; 23(3):779-85. PubMed ID: 6135149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.